## **Core Concept**
Hepatic cirrhosis is a late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcoholism. The liver's normal architecture is replaced by regenerative nodules and fibrotic bands, leading to disruption of liver function. One of the key features of cirrhosis is portal hypertension.

## **Why the Correct Answer is Right**
In hepatic cirrhosis, there's an increase in **prothrombin time (PT)**, which reflects the liver's decreased ability to synthesize clotting factors. The liver produces most of the clotting factors, including prothrombin (factor II) and factors VII, IX, and X. In cirrhosis, the liver's synthetic function is impaired, leading to decreased production of these clotting factors and, consequently, an increase in prothrombin time.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because, in cirrhosis, there's often a decrease in albumin levels due to impaired liver synthetic function. Albumin is a major protein produced by the liver, and low levels are a hallmark of liver dysfunction.
- **Option B:** This option might seem related but is not directly relevant to the typical laboratory findings in cirrhosis. While certain clotting factors might be affected, the direct and most relevant answer related to coagulation in cirrhosis is prothrombin time.
- **Option C:** This option is incorrect because, although there are changes in lipid metabolism in liver disease, the most directly related and commonly noted abnormality in cirrhosis concerning coagulation is the prolongation of prothrombin time.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **prolonged prothrombin time (PT) and international normalized ratio (INR)** are indicative of liver dysfunction, particularly in the context of cirrhosis. These tests are critical in assessing the severity of liver disease and the risk of bleeding.

## **Correct Answer:** .